Skip to main content

CORRECTION article

Front. Immunol., 19 April 2023
Sec. Mucosal Immunity
Volume 14 - 2023 | https://doi.org/10.3389/fimmu.2023.1201209

Corrigendum: Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease

This article is a correction to:

  1. Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease

    1. Read original article
Zento Yamada,Zento Yamada1,2Junko Nishio,*Junko Nishio2,3*Kaori MotomuraKaori Motomura2Satoshi MizutaniSatoshi Mizutani2Soichi YamadaSoichi Yamada2Tetuo MikamiTetuo Mikami4Toshihiro Nanki,*Toshihiro Nanki1,2*
  • 1Department of Internal Medicine, Toho University Graduate School of Medicine, Tokyo, Japan
  • 2Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan
  • 3Department of Immunopathology and Immunoregulation, Toho University School of Medicine, Tokyo, Japan
  • 4Department of Pathology, Toho University School of Medicine, Tokyo, Japan

A Corrigendum on
Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease

by Yamada Z, Nishio J, Motomura K, Mizutani S, Yamada S, Mikami T and Nanki T (2022) Front. Immunol. 13:935114. doi: 10.3389/fimmu.2022.935114

In the published article, there were errors in the approval numbers by Animal Experiment User Committee.

A correction has been made to Materials and methods, Mice. The numbers were incorrectly written as “Approval number: 19-12-432, 20-12-432 and 21-12-432”. The correct numbers are “Approval numbers: 19-41-432, 20-42-432 and 21-43-432.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: interstitial lung disease, p21, p16, senescence-associated secretary phenotype, type 2 alveolar epithelial cell, IL-6, interstitial macrophages

Citation: Yamada Z, Nishio J, Motomura K, Mizutani S, Yamada S, Mikami T and Nanki T (2023) Corrigendum: Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease. Front. Immunol. 14:1201209. doi: 10.3389/fimmu.2023.1201209

Received: 06 April 2023; Accepted: 11 April 2023;
Published: 19 April 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Yamada, Nishio, Motomura, Mizutani, Yamada, Mikami and Nanki. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Junko Nishio, junko.nishio@med.toho-u.ac.jp; Toshihiro Nanki, toshihiro.nanki@med.toho-u.ac.jp

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.